πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9993660

Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial

The United States of America as represented by the Secretary of Navy Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9988334

Salts of treprostinil

United Therapeutics Corporation Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987330

Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9982025

Monomeric griffithsin tandemers

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975926

Methods of making and using vaccines utilizing minicircle DNA expression vectors for produ

The United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974801

Methods of treating and preventing diseases and disorders of the central nervous system

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974851

Human rotavirus vaccine strains and diagnostics

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975937

Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

THE UNITED SSTATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974796

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974789

Substituted pyrazolopyrimidines as glucocerebrosidase activators

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974868

Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic reson

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9976130

OPAA FLβ€”a mutant enzyme with increased catalytic efficiency on organophosphorus compound G

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9975925

Influenza antigens and antibodies

THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968693

Small molecule imaging of fungi by positron emission tomography scanning

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968669

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndro

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9970059

Survival predictor for diffuse large B cell lymphoma

The United States of America, as Represented by the Secretary, Department of Human Services Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9968641

Method to suppress the systemic toxicity of chemotherapeutic drugs

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9962390

Mosapride sustained-release formulation providing pharmacological and clinical effects wit

KOREA UNITED PHARM. INC. Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9963450

A3 adenosine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9962379

Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9956278

Multivalent meningococcal conjugates and methods for preparing conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9956267

Method of treating skeletal dysplasias using vessel dilator

United States Department of Veteran Affairs Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9957486

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9951353

Engineering neural stem cells using homologous recombination

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted